Difference between revisions of "Age-associated neurodegeneration"
From Aging Chart
(Autoloading by CXLParser) |
(Autoloading by CXLParser) |
||
Line 225: | Line 225: | ||
(.//.)<html><!--Pop-up for: Alzheimer disease !Pop-up--> | (.//.)<html><!--Pop-up for: Alzheimer disease !Pop-up--> | ||
<div class="1HWTS9QP3-MXRNMV-12Y" style="display:none;"> | <div class="1HWTS9QP3-MXRNMV-12Y" style="display:none;"> | ||
+ | |||
<h3>Alzheimer disease</h3> | <h3>Alzheimer disease</h3> | ||
Line 230: | Line 231: | ||
</div>(...)<!--Pop-up for: Protein aggregates !Pop-up--> | </div>(...)<!--Pop-up for: Protein aggregates !Pop-up--> | ||
<div class="1HWTRDY5Y-1KGPQJM-8G" style="display:none;"> | <div class="1HWTRDY5Y-1KGPQJM-8G" style="display:none;"> | ||
+ | |||
<h3>Protein aggregates</h3> | <h3>Protein aggregates</h3> | ||
Line 235: | Line 237: | ||
</div>(...)<!--Pop-up for: Excess amino acids !Pop-up--> | </div>(...)<!--Pop-up for: Excess amino acids !Pop-up--> | ||
<div class="1HWTSJS2S-1DDC388-191" style="display:none;"> | <div class="1HWTSJS2S-1DDC388-191" style="display:none;"> | ||
+ | |||
<h3>Excess amino acids </h3> | <h3>Excess amino acids </h3> | ||
Line 240: | Line 243: | ||
</div>(...)<!--Pop-up for: IL-1b !Pop-up--> | </div>(...)<!--Pop-up for: IL-1b !Pop-up--> | ||
<div class="1N9CM8NLV-M9BNQJ-YF4" style="display:none;"> | <div class="1N9CM8NLV-M9BNQJ-YF4" style="display:none;"> | ||
+ | |||
<h3>IL-1b</h3> | <h3>IL-1b</h3> | ||
Line 245: | Line 249: | ||
</div>(...)<!--Pop-up for: Neurodegeneration !Pop-up--> | </div>(...)<!--Pop-up for: Neurodegeneration !Pop-up--> | ||
<div class="1HWTS2K9Z-TGM1HN-10H" style="display:none;"> | <div class="1HWTS2K9Z-TGM1HN-10H" style="display:none;"> | ||
+ | |||
<h3>Neurodegeneration</h3> | <h3>Neurodegeneration</h3> | ||
Line 250: | Line 255: | ||
</div>(...)<!--Pop-up for: Homoplasy of defective mtDNA !Pop-up--> | </div>(...)<!--Pop-up for: Homoplasy of defective mtDNA !Pop-up--> | ||
<div class="1HX9W0WZH-19M12RQ-15P" style="display:none;"> | <div class="1HX9W0WZH-19M12RQ-15P" style="display:none;"> | ||
+ | |||
<h3>Homoplasy of defective mtDNA</h3> | <h3>Homoplasy of defective mtDNA</h3> | ||
Line 255: | Line 261: | ||
</div>(...)<!--Pop-up for: IL-6 !Pop-up--> | </div>(...)<!--Pop-up for: IL-6 !Pop-up--> | ||
<div class="1N9CM7XT7-14T5VT3-YDM" style="display:none;"> | <div class="1N9CM7XT7-14T5VT3-YDM" style="display:none;"> | ||
+ | |||
<h3>IL-6</h3> | <h3>IL-6</h3> | ||
Line 260: | Line 267: | ||
</div>(...)<!--Pop-up for: Autophagy !Pop-up--> | </div>(...)<!--Pop-up for: Autophagy !Pop-up--> | ||
<div class="1HWTRDK80-1SG3NPM-6F" style="display:none;"> | <div class="1HWTRDK80-1SG3NPM-6F" style="display:none;"> | ||
+ | |||
<h3>Autophagy</h3> | <h3>Autophagy</h3> | ||
Line 265: | Line 273: | ||
</div>(...)<!--Pop-up for: Lipofuscin !Pop-up--> | </div>(...)<!--Pop-up for: Lipofuscin !Pop-up--> | ||
<div class="1HWTRGL1K-JPKV53-B1" style="display:none;"> | <div class="1HWTRGL1K-JPKV53-B1" style="display:none;"> | ||
+ | |||
<h3>Lipofuscin </h3> | <h3>Lipofuscin </h3> | ||
Line 270: | Line 279: | ||
</div>(...)<!--Pop-up for: IL-2 !Pop-up--> | </div>(...)<!--Pop-up for: IL-2 !Pop-up--> | ||
<div class="1N9CM8887-TFP7X1-YDW" style="display:none;"> | <div class="1N9CM8887-TFP7X1-YDW" style="display:none;"> | ||
+ | |||
<h3>IL-2</h3> | <h3>IL-2</h3> | ||
Line 275: | Line 285: | ||
</div>(...)<!--Pop-up for: Hangtington's Disease !Pop-up--> | </div>(...)<!--Pop-up for: Hangtington's Disease !Pop-up--> | ||
<div class="1HWTSBFN1-JV3LQP-156" style="display:none;"> | <div class="1HWTSBFN1-JV3LQP-156" style="display:none;"> | ||
+ | |||
<h3>Hangtington's Disease</h3> | <h3>Hangtington's Disease</h3> | ||
Line 280: | Line 291: | ||
</div>(...)<!--Pop-up for: Mitochondrial defects !Pop-up--> | </div>(...)<!--Pop-up for: Mitochondrial defects !Pop-up--> | ||
<div class="1HXDHW76K-1MK2B56-QZ" style="display:none;"> | <div class="1HXDHW76K-1MK2B56-QZ" style="display:none;"> | ||
+ | |||
<h3>Mitochondrial defects</h3> | <h3>Mitochondrial defects</h3> | ||
Line 285: | Line 297: | ||
</div>(...)<!--Pop-up for: Inflammatory Cytokines !Pop-up--> | </div>(...)<!--Pop-up for: Inflammatory Cytokines !Pop-up--> | ||
<div class="1HWTRKQ24-1WXD4Y9-KV" style="display:none;"> | <div class="1HWTRKQ24-1WXD4Y9-KV" style="display:none;"> | ||
+ | |||
<h3>Inflammatory Cytokines</h3> | <h3>Inflammatory Cytokines</h3> | ||
Line 290: | Line 303: | ||
</div>(...)<!--Pop-up for: Neurons demyelination !Pop-up--> | </div>(...)<!--Pop-up for: Neurons demyelination !Pop-up--> | ||
<div class="1HWTRTTLJ-SPX8FD-QM" style="display:none;"> | <div class="1HWTRTTLJ-SPX8FD-QM" style="display:none;"> | ||
+ | |||
<h3>Neurons demyelination</h3> | <h3>Neurons demyelination</h3> | ||
Line 295: | Line 309: | ||
</div>(...)<!--Pop-up for: Insulin resistance !Pop-up--> | </div>(...)<!--Pop-up for: Insulin resistance !Pop-up--> | ||
<div class="1HWTRZV83-Y57KSW-WL" style="display:none;"> | <div class="1HWTRZV83-Y57KSW-WL" style="display:none;"> | ||
+ | |||
<h3>Insulin resistance</h3> | <h3>Insulin resistance</h3> | ||
Line 300: | Line 315: | ||
</div>(...)<!--Pop-up for: TOR !Pop-up--> | </div>(...)<!--Pop-up for: TOR !Pop-up--> | ||
<div class="1HWTRXMKL-18FWJSB-TG" style="display:none;"> | <div class="1HWTRXMKL-18FWJSB-TG" style="display:none;"> | ||
+ | |||
<h3>TOR</h3> | <h3>TOR</h3> | ||
Line 305: | Line 321: | ||
</div>(...)<!--Pop-up for: IL-4 !Pop-up--> | </div>(...)<!--Pop-up for: IL-4 !Pop-up--> | ||
<div class="1N9CM8F31-BS5LFT-YF0" style="display:none;"> | <div class="1N9CM8F31-BS5LFT-YF0" style="display:none;"> | ||
+ | |||
<h3>IL-4</h3> | <h3>IL-4</h3> | ||
Line 310: | Line 327: | ||
</div>(...)<!--Pop-up for: Parkinson's Disease !Pop-up--> | </div>(...)<!--Pop-up for: Parkinson's Disease !Pop-up--> | ||
<div class="1HWTSB297-344VSN-143" style="display:none;"> | <div class="1HWTSB297-344VSN-143" style="display:none;"> | ||
+ | |||
<h3>Parkinson's Disease</h3> | <h3>Parkinson's Disease</h3> | ||
Line 315: | Line 333: | ||
</div>(...)<!--Pop-up for: Oxidative stress !Pop-up--> | </div>(...)<!--Pop-up for: Oxidative stress !Pop-up--> | ||
<div class="1HWTRK8CR-10B0SHS-JB" style="display:none;"> | <div class="1HWTRK8CR-10B0SHS-JB" style="display:none;"> | ||
+ | |||
<h3>Oxidative stress</h3> | <h3>Oxidative stress</h3> | ||
Line 320: | Line 339: | ||
</div>(...)<!--Pop-up for: Apoptosis of neurons !Pop-up--> | </div>(...)<!--Pop-up for: Apoptosis of neurons !Pop-up--> | ||
<div class="1HWTRHHSP-5MW4YS-CN" style="display:none;"> | <div class="1HWTRHHSP-5MW4YS-CN" style="display:none;"> | ||
+ | |||
<h3>Apoptosis of neurons</h3> | <h3>Apoptosis of neurons</h3> | ||
Line 325: | Line 345: | ||
</div>(...)<!--Pop-up for: IL-12 !Pop-up--> | </div>(...)<!--Pop-up for: IL-12 !Pop-up--> | ||
<div class="1N9CM82LJ-26Z61H5-YDR" style="display:none;"> | <div class="1N9CM82LJ-26Z61H5-YDR" style="display:none;"> | ||
+ | |||
<h3>IL-12</h3> | <h3>IL-12</h3> | ||
Line 330: | Line 351: | ||
</div>(...)<!--Pop-up for: Metabolic neurons dysfunction !Pop-up--> | </div>(...)<!--Pop-up for: Metabolic neurons dysfunction !Pop-up--> | ||
<div class="1HWTRVJNH-W2NY0Q-RH" style="display:none;"> | <div class="1HWTRVJNH-W2NY0Q-RH" style="display:none;"> | ||
+ | |||
<h3>Metabolic neurons dysfunction</h3> | <h3>Metabolic neurons dysfunction</h3> | ||
Line 335: | Line 357: | ||
</div>(...)<!--Pop-up for: TNF-a !Pop-up--> | </div>(...)<!--Pop-up for: TNF-a !Pop-up--> | ||
<div class="1N9CM8T4D-1PXBGJN-YF8" style="display:none;"> | <div class="1N9CM8T4D-1PXBGJN-YF8" style="display:none;"> | ||
+ | |||
<h3>TNF-a</h3> | <h3>TNF-a</h3> |
Revision as of 13:43, 26 February 2015